Skip to main content
. 2022 Mar 23;10(4):490. doi: 10.3390/vaccines10040490

Figure 2.

Figure 2

Participants’ estimated risk of getting sick and of negative reactions to vaccination, in relation to evaluations of PCV-13 and PPSV-23.3.1.